0874.HK Sygnały na żywo | Maksymalizuj zyski z Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 geg. 2024 @ 11:08):

Stats
Dzisiejszy wolumen	218 000
Średni wolumen	775 945
Kapitalizacja rynkowa	51.97B
EPS	HKD0.600 ( 2023-10-30 )
Last Dividend	HKD0.813 ( 2023-06-14 )
Next Dividend	HKD0 ( N/A )
P/E	7.82
ATR14	HKD0.0490 (0.23%)

Wolumen Korelacja

Długi: 0.02 (neutral)

Krótki: 0.07 (neutral)

Signal:(59.069) Neutral

Guangzhou Baiyunshan Korelacja

10 Najbardziej pozytywne korelacje

10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Guangzhou Baiyunshan Korelacja - Waluta/Towar

-0.58
( weak negative )

-0.61
( weak negative )

0.00
( neutral )

-0.71
( moderate negative )

0.30
( neutral )

0.66
( moderate )

Guangzhou Baiyunshan Finanse

Annual	2023
Przychody:	HKD75.52B
Zysk brutto:	HKD14.19B (18.79 %)
EPS:	HKD2.50

FY	2023
Przychody:	HKD75.52B
Zysk brutto:	HKD14.19B (18.79 %)
EPS:	HKD2.50

FY	2022
Przychody:	HKD70.79B
Zysk brutto:	HKD13.28B (18.76 %)
EPS:	HKD2.44

FY	2021
Przychody:	HKD69.01B
Zysk brutto:	HKD13.23B (19.17 %)
EPS:	HKD2.29

Financial Reports:

No articles found.

Guangzhou Baiyunshan Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0.813 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)	HKD0 (N/A)

Guangzhou Baiyunshan Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 4.73 - Stable (5.39%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	HKD0.0300	2000-04-20
Last Dividend	HKD0.813	2023-06-14
Next Dividend	HKD0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	25	--
Total Paid Out	HKD6.04	--
Avg. Dividend % Per Year	0.00%	--
Score	3.2	--
Div. Sustainability Score	10.00
Div.Growth Potential Score	4.73
Div. Directional Score	8.17	--

Next Divdend (Est)
(2025-02-21)

HKD0.870 Estimate 3.15 %

Dividend Stability

0.25 Very Poor

Dividend Score

3.20

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for HKSE

Symbol	Title	Last dividend	Frequency	Yearly Dividend
8371.HK	Ex Dividend Junior	2023-08-03	Annually	0.00%
2018.HK	Ex Dividend Knight	2023-05-29	Annually	0.00%
1088.HK	Ex Dividend Knight	2023-06-21	Annually	0.00%
0158.HK	Ex Dividend Junior	2023-06-15	Semi-Annually	0.00%
3737.HK	Ex Dividend Junior	2023-10-17	Annually	0.00%
1665.HK	Ex Dividend Junior	2023-06-05	Annually	0.00%
0697.HK	Ex Dividend Knight	2023-09-28	Semi-Annually	0.00%
2219.HK	Ex Dividend Junior	2023-06-12	Annually	0.00%
1224.HK	No Dividend Player	2023-05-24	Annually	0.00%
0297.HK	Ex Dividend Junior	2023-06-23	Sporadic	0.00%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0534	1.500	8.93	10.00	[0 - 0.5]
returnOnAssetsTTM	0.0522	1.200	8.26	9.91	[0 - 0.3]
returnOnEquityTTM	0.117	1.500	9.81	10.00	[0.1 - 1]
payoutRatioTTM	0.383	-1.000	6.17	-6.17	[0 - 1]
currentRatioTTM	1.640	0.800	6.80	5.44	[1 - 3]
quickRatioTTM	1.302	0.800	7.05	5.64	[0.8 - 2.5]
cashRatioTTM	0.579	1.500	7.89	10.00	[0.2 - 2]
debtRatioTTM	0.175	-1.500	7.08	-10.00	[0 - 0.6]
interestCoverageTTM	11.84	1.000	6.73	6.73	[3 - 30]
operatingCashFlowPerShareTTM	2.34	2.00	9.22	10.00	[0 - 30]
freeCashFlowPerShareTTM	1.286	2.00	9.36	10.00	[0 - 20]
debtEquityRatioTTM	0.374	-1.500	8.50	-10.00	[0 - 2.5]
grossProfitMarginTTM	0.185	1.000	-0.246	-0.246	[0.2 - 0.8]
operatingProfitMarginTTM	0.0679	1.000	-0.641	-0.641	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0.276	1.000	9.58	9.58	[0.2 - 2]
assetTurnoverTTM	0.976	0.800	6.83	5.46	[0.5 - 2]
Total Score				11.62

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	7.82	1.000	9.31	0	[1 - 100]
returnOnEquityTTM	0.117	2.50	9.88	10.00	[0.1 - 1.5]
freeCashFlowPerShareTTM	1.286	2.00	9.57	10.00	[0 - 30]
dividendYielPercentageTTM	4.12	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	2.34	2.00	9.22	10.00	[0 - 30]
payoutRatioTTM	0.383	1.500	6.17	-6.17	[0 - 1]
pegRatioTTM	-0.973	1.500	-9.82	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0495	1.000	-1.262	0	[0.1 - 0.5]
Total Score				4.73

Guangzhou Baiyunshan

Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern TCM, Great Commerce, Great Health, and Others. It is also involved in the wholesale, retail, import, and export of Western and Chinese medicines, and medical apparatus and instruments; and research and development, production, and sale of beverages, food, healthcare products, pre-packaging food, dairy products, tablets, capsules, lozenges, injections, tortoise herb jelly, etc. In addition, the company invests in health industry, such as medical care, health management, health preservation, elderly care, etc.; and provides commercial and advertising services. As of December 31, 2021, it had 154 retail chain pharmacy outlets, which included 22 Cai Zhi Lin pharmacy outlets, 36 Jian Min pharmacy outlets, 51 GPC Prescription Pharmacy outlets, and 23 Hainan Guangyao Chenfei Pharmaceutical Chain Co., Ltd outlets, as well as 22 retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.